Symbols / ERNA $0.21 +4.59% Ernexa Therapeutics Inc.
ERNA Chart
About
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-201, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 6.11M |
| Enterprise Value | 4.45M | Income | -14.10M | Sales | — |
| Book/sh | 0.31 | Cash/sh | 0.07 | Dividend Yield | — |
| Payout | 0.00% | Employees | 5 | IPO | — |
| P/E | 0.00 | Forward P/E | -0.02 | PEG | — |
| P/S | — | P/B | 0.69 | P/C | — |
| EV/EBITDA | -0.48 | EV/Sales | — | Quick Ratio | 0.88 |
| Current Ratio | 1.01 | Debt/Eq | 20.41 | LT Debt/Eq | — |
| EPS (ttm) | -2.24 | EPS next Y | -9.60 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2022-11-14 16:00 | ROA | -104.92% |
| ROE | -6.87% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 29.15M |
| Shs Float | 20.45M | Short Float | 0.50% | Short Ratio | 0.03 |
| Short Interest | — | 52W High | 4.05 | 52W Low | 0.18 |
| Beta | 6.85 | Avg Volume | 1.70M | Volume | 397.65K |
| Target Price | — | Recom | None | Prev Close | $0.20 |
| Price | $0.21 | Change | 4.59% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- $ERNA stock is up 14% today. Here's what we see in our data. - Quiver Quantitative ue, 10 Mar 2026 07
- Ernexa Therapeutics (NASDAQ: ERNA) OKs Board-authorized 1-for-10–1-for-25 reverse split - Stock Titan Wed, 01 Apr 2026 21
- Hot Trades Live - CMBM Stock - PPBT Stock - ERNA Stock - FUBO - FGL - TLIH - PFSA - VSEE - SPY [ce1360] - Fathom Journal Sat, 04 Apr 2026 19
- ERNA Stock Price and Chart — NASDAQ:ERNA - TradingView Mon, 03 Nov 2025 08
- Eterna Therapeutics Faces Nasdaq Delisting Risk After Notice - The Globe and Mail Sat, 21 Mar 2026 07
- Ernexa therapeutics ten percent owner Cherington buys $2m in stock - Investing.com ue, 17 Feb 2026 08
- ERNA PE Ratio & Valuation, Is ERNA Overvalued - Intellectia AI Sat, 04 Apr 2026 15
- ERNA Stock Rallies On Collaboration With Contract Manufacturer To Advance Lead Cell Therapy Into Clinical Trials - Stocktwits Wed, 29 Oct 2025 07
- Deep tumor regressions put Ernexa on track for 2026 human trial - Stock Titan ue, 31 Mar 2026 12
- Ernexa Therapeutics announces 1-for-15 reverse stock split - Yahoo Finance Wed, 11 Jun 2025 07
- Ernexa Therapeutics Signs Multiple Financing Agreements - TradingView Wed, 11 Feb 2026 08
- Cancer cell therapy firm Ernexa prices $10.5M stock, warrant sale - Stock Titan Fri, 06 Feb 2026 08
- Insider Purchase: 10% owner at $ERNA Buys 4,000,000 Shares | ERNA Stock News - Quiver Quantitative Wed, 18 Feb 2026 08
- [EFFECT] Ernexa Therapeutics Inc. SEC Filing - Stock Titan ue, 31 Mar 2026 04
- Ernexa Therapeutics Inc. Announces Pricing of $10.5 Million Public Offering of Common Stock and Warrants - Quiver Quantitative Fri, 06 Feb 2026 08
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
-100.00%
|
0.58
+755.88%
|
0.07
|
0.00
|
| Operating Revenue |
|
0.00
-100.00%
|
0.58
+755.88%
|
0.07
|
0.00
|
| Cost Of Revenue |
|
0.00
-100.00%
|
0.10
-59.32%
|
0.24
|
0.00
|
| Reconciled Cost Of Revenue |
|
0.00
-100.00%
|
0.10
-59.32%
|
0.24
|
0.00
|
| Gross Profit |
|
0.00
-100.00%
|
0.49
+389.29%
|
-0.17
|
0.00
|
| Operating Expense |
|
9.32
-47.46%
|
17.74
-13.51%
|
20.51
-23.90%
|
26.95
|
| Research And Development |
|
4.16
-9.73%
|
4.60
-22.23%
|
5.92
-43.03%
|
10.39
|
| Selling General And Administration |
|
5.16
-60.68%
|
13.13
-9.97%
|
14.59
-11.89%
|
16.55
|
| General And Administrative Expense |
|
5.16
-60.68%
|
13.13
-9.97%
|
14.59
-11.89%
|
16.55
|
| Salaries And Wages |
|
2.86
-5.73%
|
3.04
-0.49%
|
3.05
-34.03%
|
4.63
|
| Other Gand A |
|
2.00
-55.76%
|
4.52
-36.19%
|
7.09
-24.08%
|
9.34
|
| Total Expenses |
|
9.32
-47.74%
|
17.83
-14.03%
|
20.74
-23.02%
|
26.95
|
| Operating Income |
|
-9.32
+45.98%
|
-17.25
+16.57%
|
-20.68
+23.28%
|
-26.95
|
| Total Operating Income As Reported |
|
-9.32
+40.54%
|
-15.67
+25.84%
|
-21.14
+36.37%
|
-33.22
|
| EBITDA |
|
-13.84
+61.68%
|
-36.12
-81.19%
|
-19.93
+16.97%
|
-24.01
|
| Normalized EBITDA |
|
-8.76
+42.73%
|
-15.29
+22.56%
|
-19.75
+28.43%
|
-27.59
|
| Reconciled Depreciation |
|
0.26
-83.94%
|
1.64
+45.86%
|
1.12
+125.96%
|
0.50
|
| EBIT |
|
-14.10
+62.65%
|
-37.76
-79.31%
|
-21.06
+14.07%
|
-24.50
|
| Total Unusual Items |
|
-5.08
+75.60%
|
-20.83
-11096.77%
|
-0.19
-105.19%
|
3.58
|
| Total Unusual Items Excluding Goodwill |
|
-5.08
+75.60%
|
-20.83
-11096.77%
|
-0.19
-105.19%
|
3.58
|
| Special Income Charges |
|
0.77
+103.68%
|
-20.80
-5981.29%
|
-0.34
+94.55%
|
-6.27
|
| Other Special Charges |
|
-0.77
-103.67%
|
20.86
+4435.65%
|
0.46
|
—
|
| Restructuring And Mergern Acquisition |
|
0.00
+100.00%
|
-0.07
+44.07%
|
-0.12
|
0.00
|
| Write Off |
|
—
|
—
|
0.00
-100.00%
|
5.99
|
| Net Income |
|
-14.08
+68.38%
|
-44.54
-105.55%
|
-21.67
+11.84%
|
-24.58
|
| Pretax Income |
|
-14.13
+68.26%
|
-44.51
-105.39%
|
-21.67
+11.67%
|
-24.53
|
| Net Non Operating Interest Income Expense |
|
0.06
+100.86%
|
-6.50
-1266.18%
|
-0.48
-1486.67%
|
-0.03
|
| Interest Expense Non Operating |
|
0.03
-99.60%
|
6.75
+999.67%
|
0.61
+1946.67%
|
0.03
|
| Net Interest Income |
|
0.06
+100.86%
|
-6.50
-1266.18%
|
-0.48
-1486.67%
|
-0.03
|
| Interest Expense |
|
0.03
-99.60%
|
6.75
+999.67%
|
0.61
+1946.67%
|
0.03
|
| Interest Income Non Operating |
|
0.08
-66.67%
|
0.25
+80.43%
|
0.14
|
0.00
|
| Interest Income |
|
0.08
-66.67%
|
0.25
+80.43%
|
0.14
|
0.00
|
| Other Income Expense |
|
-4.87
+76.56%
|
-20.76
-3891.54%
|
-0.52
-121.29%
|
2.44
|
| Other Non Operating Income Expenses |
|
0.21
+207.14%
|
0.07
+120.96%
|
-0.33
+70.73%
|
-1.14
|
| Gain On Sale Of Security |
|
-5.85
-20778.57%
|
-0.03
-117.95%
|
0.16
-98.42%
|
9.85
|
| Tax Provision |
|
-0.04
-250.00%
|
0.03
+1100.00%
|
-0.00
-106.67%
|
0.04
|
| Tax Rate For Calcs |
|
0.00
-98.52%
|
0.00
+209900.00%
|
0.00
-99.95%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.02
+99.64%
|
-4.37
-23513125.81%
|
-0.00
-100.00%
|
0.75
|
| Net Income Including Noncontrolling Interests |
|
-14.08
+68.38%
|
-44.54
-105.55%
|
-21.67
+11.84%
|
-24.58
|
| Net Income From Continuing Operation Net Minority Interest |
|
-14.08
+68.38%
|
-44.54
-105.55%
|
-21.67
+11.84%
|
-24.58
|
| Net Income From Continuing And Discontinued Operation |
|
-14.08
+68.38%
|
-44.54
-105.55%
|
-21.67
+11.84%
|
-24.58
|
| Net Income Continuous Operations |
|
-14.08
+68.38%
|
-44.54
-105.55%
|
-21.67
+11.84%
|
-24.58
|
| Normalized Income |
|
-9.02
+67.89%
|
-28.09
-30.74%
|
-21.48
+21.63%
|
-27.41
|
| Net Income Common Stockholders |
|
-14.10
+68.35%
|
-44.55
-105.47%
|
-21.68
+11.84%
|
-24.59
|
| Diluted EPS |
|
—
|
-48.96
+20.00%
|
-61.20
+49.38%
|
-120.90
|
| Basic EPS |
|
—
|
-48.96
+20.00%
|
-61.20
+49.38%
|
-120.90
|
| Basic Average Shares |
|
—
|
0.91
+156.87%
|
0.35
+74.17%
|
0.20
|
| Diluted Average Shares |
|
—
|
0.91
+156.87%
|
0.35
+74.17%
|
0.20
|
| Diluted NI Availto Com Stockholders |
|
-14.10
+68.35%
|
-44.55
-105.47%
|
-21.68
+11.84%
|
-24.59
|
| Gain On Sale Of PPE |
|
—
|
—
|
-0.00
+99.64%
|
-0.28
|
| Insurance And Claims |
|
0.27
-45.88%
|
0.50
-56.40%
|
1.14
-41.57%
|
1.95
|
| Other Taxes |
|
—
|
—
|
—
|
—
|
| Preferred Stock Dividends |
|
0.02
+0.00%
|
0.02
+0.00%
|
0.02
+0.00%
|
0.02
|
| Rent And Landing Fees |
|
0.03
-99.43%
|
5.07
+53.48%
|
3.31
+416.56%
|
0.64
|
| Rent Expense Supplemental |
|
0.03
-99.43%
|
5.07
+53.48%
|
3.31
+416.56%
|
0.64
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
5.83
+10.72%
|
5.27
-89.28%
|
49.13
+120.53%
|
22.28
|
| Current Assets |
|
3.13
+33.21%
|
2.35
-75.50%
|
9.60
-29.84%
|
13.68
|
| Cash Cash Equivalents And Short Term Investments |
|
1.88
+8.96%
|
1.73
-77.17%
|
7.58
-33.82%
|
11.45
|
| Cash And Cash Equivalents |
|
1.88
+8.96%
|
1.73
-77.17%
|
7.58
-33.82%
|
11.45
|
| Cash Financial |
|
1.88
+8.96%
|
1.73
-77.17%
|
7.58
-33.82%
|
11.45
|
| Receivables |
|
0.84
+93.36%
|
0.44
+2.82%
|
0.42
-55.31%
|
0.95
|
| Accounts Receivable |
|
—
|
—
|
—
|
—
|
| Other Receivables |
|
0.10
-78.26%
|
0.44
+2.82%
|
0.42
-55.31%
|
0.95
|
| Prepaid Assets |
|
—
|
—
|
—
|
1.28
|
| Other Current Assets |
|
0.40
+117.20%
|
0.19
-88.37%
|
1.60
+24.53%
|
1.28
|
| Total Non Current Assets |
|
2.70
-7.40%
|
2.92
-92.62%
|
39.53
+359.79%
|
8.60
|
| Net PPE |
|
0.55
-27.55%
|
0.76
-97.73%
|
33.27
+2528.28%
|
1.27
|
| Gross PPE |
|
0.74
-19.74%
|
0.93
-97.22%
|
33.39
+2472.27%
|
1.30
|
| Accumulated Depreciation |
|
-0.20
-14.53%
|
-0.17
-50.88%
|
-0.11
-256.25%
|
-0.03
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
0.22
-4.80%
|
0.23
-21.84%
|
0.29
+22.08%
|
0.24
|
| Other Properties |
|
0.46
-34.38%
|
0.70
-97.87%
|
32.82
+3002.17%
|
1.06
|
| Leases |
|
0.07
|
0.00
-100.00%
|
0.27
|
0.00
|
| Goodwill And Other Intangible Assets |
|
2.04
+0.00%
|
2.04
+0.00%
|
2.04
+0.00%
|
2.04
|
| Goodwill |
|
2.04
+0.00%
|
2.04
+0.00%
|
2.04
+0.00%
|
2.04
|
| Other Intangible Assets |
|
—
|
—
|
—
|
—
|
| Investments And Advances |
|
—
|
—
|
0.00
-100.00%
|
0.06
|
| Long Term Equity Investment |
|
—
|
—
|
0.00
-100.00%
|
0.06
|
| Non Current Prepaid Assets |
|
—
|
—
|
—
|
—
|
| Other Non Current Assets |
|
0.11
-6.78%
|
0.12
-97.20%
|
4.21
-19.39%
|
5.23
|
| Total Liabilities Net Minority Interest |
|
3.43
-3.78%
|
3.57
-92.39%
|
46.90
+361.06%
|
10.17
|
| Current Liabilities |
|
3.11
+5.96%
|
2.94
-55.30%
|
6.57
-14.12%
|
7.65
|
| Payables And Accrued Expenses |
|
2.76
+1.66%
|
2.72
-33.00%
|
4.06
-31.58%
|
5.93
|
| Payables |
|
1.88
+8.93%
|
1.72
-24.19%
|
2.27
-32.52%
|
3.37
|
| Accounts Payable |
|
1.12
-34.63%
|
1.72
+61.29%
|
1.07
-34.14%
|
1.62
|
| Current Accrued Expenses |
|
0.89
-10.95%
|
0.99
-44.23%
|
1.78
-30.34%
|
2.56
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.01
+0.00%
|
0.01
-88.99%
|
0.11
-89.77%
|
1.06
|
| Total Tax Payable |
|
0.00
+0.00%
|
0.00
+50.00%
|
0.00
|
0.00
|
| Income Tax Payable |
|
0.00
+0.00%
|
0.00
+50.00%
|
0.00
|
0.00
|
| Current Debt And Capital Lease Obligation |
|
0.21
+2.90%
|
0.21
-90.66%
|
2.22
+651.19%
|
0.29
|
| Current Debt |
|
—
|
—
|
—
|
1.75
|
| Other Current Borrowings |
|
—
|
—
|
—
|
1.75
|
| Current Capital Lease Obligation |
|
0.21
+2.90%
|
0.21
-90.66%
|
2.22
+651.19%
|
0.29
|
| Current Deferred Liabilities |
|
—
|
0.00
-100.00%
|
0.19
|
0.00
|
| Current Deferred Revenue |
|
—
|
0.00
-100.00%
|
0.19
|
0.00
|
| Other Current Liabilities |
|
0.12
|
—
|
—
|
0.36
|
| Total Non Current Liabilities Net Minority Interest |
|
0.32
-49.21%
|
0.63
-98.44%
|
40.33
+1501.51%
|
2.52
|
| Long Term Debt And Capital Lease Obligation |
|
0.28
-41.93%
|
0.48
-98.80%
|
39.63
+4367.53%
|
0.89
|
| Long Term Debt |
|
—
|
—
|
6.77
+461.61%
|
1.21
|
| Long Term Capital Lease Obligation |
|
0.28
-41.93%
|
0.48
-98.55%
|
32.85
+3603.95%
|
0.89
|
| Tradeand Other Payables Non Current |
|
—
|
—
|
0.00
|
0.00
|
| Non Current Deferred Liabilities |
|
—
|
0.00
-100.00%
|
0.39
|
0.00
|
| Non Current Deferred Revenue |
|
—
|
0.00
-100.00%
|
0.39
|
0.00
|
| Other Non Current Liabilities |
|
0.04
-71.71%
|
0.15
-20.42%
|
0.19
+103.19%
|
0.09
|
| Stockholders Equity |
|
2.40
+41.15%
|
1.70
-23.82%
|
2.23
-81.56%
|
12.11
|
| Common Stock Equity |
|
2.40
+41.18%
|
1.70
-23.84%
|
2.23
-81.56%
|
12.11
|
| Capital Stock |
|
0.04
+122.22%
|
0.02
-35.71%
|
0.03
+3.70%
|
0.03
|
| Common Stock |
|
0.04
+129.41%
|
0.02
-37.04%
|
0.03
+3.85%
|
0.03
|
| Preferred Stock |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Share Issued |
|
7.85
+129.26%
|
3.43
+849.78%
|
0.36
+5.53%
|
0.34
|
| Ordinary Shares Number |
|
7.85
+129.26%
|
3.43
+849.78%
|
0.36
+5.53%
|
0.34
|
| Additional Paid In Capital |
|
248.00
+6.34%
|
233.22
+23.27%
|
189.19
+6.66%
|
177.38
|
| Retained Earnings |
|
-245.64
-6.09%
|
-231.54
-23.83%
|
-186.98
-13.12%
|
-165.30
|
| Total Equity Gross Minority Interest |
|
2.40
+41.15%
|
1.70
-23.82%
|
2.23
-81.56%
|
12.11
|
| Total Capitalization |
|
2.40
+41.15%
|
1.70
-81.11%
|
9.01
-25.61%
|
12.11
|
| Working Capital |
|
0.02
+103.41%
|
-0.59
-119.37%
|
3.03
-49.79%
|
6.03
|
| Invested Capital |
|
2.40
+41.18%
|
1.70
-81.12%
|
9.01
-25.62%
|
12.11
|
| Total Debt |
|
0.49
-28.36%
|
0.68
-98.37%
|
41.84
+3440.02%
|
1.18
|
| Capital Lease Obligations |
|
0.49
-28.36%
|
0.68
-98.05%
|
35.07
+2867.01%
|
1.18
|
| Net Tangible Assets |
|
0.36
+204.08%
|
-0.34
-281.48%
|
0.19
-98.12%
|
10.06
|
| Tangible Book Value |
|
0.36
+203.49%
|
-0.34
-282.98%
|
0.19
-98.13%
|
10.06
|
| Current Notes Payable |
|
—
|
—
|
—
|
—
|
| Derivative Product Liabilities |
|
0.00
-100.00%
|
0.00
-99.14%
|
0.12
-64.95%
|
0.33
|
| Duefrom Related Parties Current |
|
0.75
|
0.00
|
—
|
—
|
| Dueto Related Parties Current |
|
0.75
|
0.00
-100.00%
|
1.21
-31.14%
|
1.75
|
| Dueto Related Parties Non Current |
|
—
|
—
|
0.00
-100.00%
|
1.21
|
| Interest Payable |
|
—
|
0.00
-100.00%
|
0.18
|
0.00
|
| Preferred Stock Equity |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-7.02
+55.69%
|
-15.84
+22.40%
|
-20.41
+2.71%
|
-20.98
|
| Cash Flow From Continuing Operating Activities |
|
-7.02
+55.69%
|
-15.84
+22.40%
|
-20.41
+2.71%
|
-20.98
|
| Net Income From Continuing Operations |
|
-14.08
+68.38%
|
-44.54
-105.55%
|
-21.67
+11.84%
|
-24.58
|
| Depreciation Amortization Depletion |
|
0.26
-83.94%
|
1.64
+45.86%
|
1.12
+125.96%
|
0.50
|
| Depreciation |
|
0.26
-83.94%
|
1.64
+45.86%
|
1.12
+125.96%
|
0.50
|
| Depreciation And Amortization |
|
0.26
-83.94%
|
1.64
+45.86%
|
1.12
+125.96%
|
0.50
|
| Other Non Cash Items |
|
0.23
-95.41%
|
5.05
+315.80%
|
1.22
+467.76%
|
0.21
|
| Stock Based Compensation |
|
1.50
-1.58%
|
1.52
+22.38%
|
1.24
-57.68%
|
2.94
|
| Asset Impairment Charge |
|
0.03
|
0.00
|
0.00
-100.00%
|
6.76
|
| Operating Gains Losses |
|
5.09
-78.31%
|
23.48
+11668.97%
|
-0.20
+98.07%
|
-10.52
|
| Gain Loss On Investment Securities |
|
5.85
+459.43%
|
1.04
+586.05%
|
-0.21
+98.01%
|
-10.79
|
| Unrealized Gain Loss On Investment Securities |
|
0.00
+100.00%
|
-1.02
|
0.00
|
—
|
| Gain Loss On Sale Of PPE |
|
0.01
|
0.00
-100.00%
|
0.00
-99.64%
|
0.28
|
| Change In Working Capital |
|
-0.05
+97.42%
|
-1.98
+6.71%
|
-2.12
-157.06%
|
3.71
|
| Change In Receivables |
|
-0.41
-3300.00%
|
-0.01
-102.28%
|
0.53
+301.15%
|
-0.26
|
| Changes In Account Receivables |
|
—
|
—
|
—
|
—
|
| Change In Prepaid Assets |
|
-0.27
-120.32%
|
1.32
+337.23%
|
-0.56
-197.33%
|
-0.19
|
| Change In Payables And Accrued Expense |
|
0.81
+179.26%
|
-1.02
+78.01%
|
-4.65
-193.15%
|
4.99
|
| Change In Payable |
|
0.81
+179.26%
|
-1.02
+78.01%
|
-4.65
-193.15%
|
4.99
|
| Change In Account Payable |
|
0.06
-67.21%
|
0.18
+106.31%
|
-2.90
-242.48%
|
2.03
|
| Change In Other Working Capital |
|
—
|
-0.58
-200.00%
|
0.58
|
—
|
| Change In Other Current Assets |
|
0.01
+300.00%
|
0.00
-99.80%
|
1.01
+256.97%
|
-0.65
|
| Change In Other Current Liabilities |
|
-0.19
+88.51%
|
-1.68
-274.27%
|
0.96
+621.08%
|
-0.18
|
| Investing Cash Flow |
|
-0.04
+89.86%
|
-0.36
-1821.05%
|
-0.02
+59.57%
|
-0.05
|
| Cash Flow From Continuing Investing Activities |
|
-0.04
+89.86%
|
-0.36
-1821.05%
|
-0.02
+59.57%
|
-0.05
|
| Net PPE Purchase And Sale |
|
-0.04
+89.86%
|
-0.36
-1821.05%
|
-0.02
+59.57%
|
-0.05
|
| Purchase Of PPE |
|
-0.04
+89.97%
|
-0.37
-1842.11%
|
-0.02
+93.60%
|
-0.30
|
| Sale Of PPE |
|
0.00
-100.00%
|
0.00
|
0.00
-100.00%
|
0.25
|
| Capital Expenditure |
|
-0.04
+89.97%
|
-0.37
-1842.11%
|
-0.02
+93.60%
|
-0.30
|
| Net Business Purchase And Sale |
|
—
|
—
|
—
|
0.00
|
| Purchase Of Business |
|
—
|
—
|
—
|
0.00
|
| Gain Loss On Sale Of Business |
|
—
|
0.00
-100.00%
|
0.01
|
—
|
| Net Other Investing Changes |
|
—
|
—
|
—
|
—
|
| Financing Cash Flow |
|
7.21
+15.16%
|
6.26
-62.19%
|
16.56
-15.44%
|
19.58
|
| Cash Flow From Continuing Financing Activities |
|
7.21
+15.16%
|
6.26
-62.19%
|
16.56
-15.44%
|
19.58
|
| Net Issuance Payments Of Debt |
|
2.25
-57.48%
|
5.29
-67.93%
|
16.50
+825250.00%
|
-0.00
|
| Issuance Of Debt |
|
2.25
-57.48%
|
5.29
-70.60%
|
18.00
|
0.00
|
| Repayment Of Debt |
|
—
|
0.00
+100.00%
|
-1.50
-74900.00%
|
-0.00
|
| Long Term Debt Issuance |
|
2.25
-57.48%
|
5.29
-70.60%
|
18.00
|
0.00
|
| Long Term Debt Payments |
|
—
|
0.00
+100.00%
|
-1.50
-74900.00%
|
-0.00
|
| Net Long Term Debt Issuance |
|
2.25
-57.48%
|
5.29
-67.93%
|
16.50
+825250.00%
|
-0.00
|
| Short Term Debt Issuance |
|
—
|
3.89
|
0.00
|
0.00
|
| Net Short Term Debt Issuance |
|
—
|
3.89
|
0.00
|
0.00
|
| Net Common Stock Issuance |
|
4.93
+333.51%
|
1.14
+255.31%
|
0.32
-98.38%
|
19.71
|
| Cash Dividends Paid |
|
—
|
0.00
+100.00%
|
-0.02
+0.00%
|
-0.02
|
| Proceeds From Stock Option Exercised |
|
0.03
|
0.00
|
0.00
-100.00%
|
0.01
|
| Net Other Financing Charges |
|
—
|
-0.17
+32.67%
|
-0.25
-116.38%
|
-0.12
|
| Changes In Cash |
|
0.15
+101.56%
|
-9.94
-156.81%
|
-3.87
-168.07%
|
-1.44
|
| Beginning Cash Position |
|
1.73
-85.18%
|
11.67
-24.91%
|
15.54
-8.50%
|
16.98
|
| End Cash Position |
|
1.88
+8.96%
|
1.73
-85.18%
|
11.67
-24.91%
|
15.54
|
| Free Cash Flow |
|
-7.05
+56.47%
|
-16.20
+20.67%
|
-20.43
+3.98%
|
-21.27
|
| Interest Paid Supplemental Data |
|
0.01
-87.50%
|
0.05
+140.00%
|
0.02
-33.33%
|
0.03
|
| Income Tax Paid Supplemental Data |
|
0.00
+0.00%
|
0.00
-25.00%
|
0.00
-73.33%
|
0.01
|
| Common Stock Issuance |
|
4.93
+333.51%
|
1.14
+255.31%
|
0.32
-98.38%
|
19.71
|
| Issuance Of Capital Stock |
|
4.93
+333.51%
|
1.14
+255.31%
|
0.32
-98.38%
|
19.71
|
| Net Preferred Stock Issuance |
|
—
|
1.14
|
0.00
|
—
|
| Preferred Stock Dividend Paid |
|
—
|
0.00
+100.00%
|
-0.02
+0.00%
|
-0.02
|
| Preferred Stock Issuance |
|
—
|
1.14
|
0.00
|
—
|
| Sale Of Business |
|
—
|
—
|
—
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-03-20 View
- 10-K2026-03-13 View
- 8-K2026-02-26 View
- 42026-02-17 View
- 8-K2026-02-11 View
- 8-K2025-12-11 View
- 10-Q2025-11-07 View
- 10-Q2025-08-13 View
- 42025-07-07 View
- 8-K2025-07-07 View
- 8-K2025-06-12 View
- 42025-06-11 View
- 8-K2025-06-09 View
- 8-K2025-06-02 View
- 10-Q2025-05-07 View
- 42025-04-04 View
- 8-K2025-04-03 View
- 8-K2025-03-26 View
- 8-K2025-03-24 View
- 10-K2025-03-12 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|